Head-to-Head

Arcturus Therapeutics Holdings Inc. Common Stock vs. Eli Lilly & Co.

ARCT

Arcturus Therapeutics Holdings Inc. Common Stock

$14.46 -4.77%

VS LLY

Eli Lilly & Co.

$1159.57 -1.28%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.

Size & Scale

ARCTLLY
Market Cap $431.75 million $1.05 trillion
Revenue (TTM) $29.37 million $79.67 billion
Net Income (TTM) $-93,276,000 $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

ARCTLLY
P/E Ratio — 38.92
Price / Book 2.51 30.90
Price / Sales 14.70 13.14

ARCT and LLY split the valuation factors evenly.

Profitability

ARCTLLY
Net Margin -317.62% 33.53%
Return on Equity -54.29% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

ARCTLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

ARCT and LLY split the dividend factors evenly.

Risk & Sentiment

ARCTLLY
Short Interest 0.22% 1.29%

ARCT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ARCT overview, ARCT financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.